1. Immunotherapeutic, Antiagglutination (Liu et al

2. Currently, several passive and active immunotherapeutic approaches are being tested in clinical trials.

3. The active and passive immunotherapeutic combination can be used simultaneously or sequentially depending on whether the therapeutic method is being used in patients with an advanced disease state or as adjuvant therapy.